Properzi C, et al. - Researchers conducted this randomized controlled trial to determine how two ad libitum isocaloric diets (Mediterranean [MD] or low fat [LF]) impact hepatic steatosis (HS) and cardiometabolic risk factors. For this investigation, they randomized study participants with NAFLD to a 12-week blinded dietary intervention (MD vs LF). Out of 56 recruited participants, 49 completed the intervention and 48 were involved for analysis. Findings suggested that both ad libitum MD and LF diets improve HS to a similar degree. Compared with LF, however, adherence was higher for the MD diet.